Eriko Ohgitani
Impact in
- Biophysics top 5%
- Spectroscopy Techniques in Biomedical and Chemical Research
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Antifungal resistance and susceptibility
Papers in
-
- SARS-CoV-2 and COVID-19 Research 5
- SARS-CoV-2 detection and testing 4
- Antifungal resistance and susceptibility 4
- Co-authors
- Osam Mazda (32 shared papers)Wenliang Zhu (21 shared papers)Elia Marin (21 shared papers)Giuseppe Pezzotti (22 shared papers)Tetsuya Adachi (19 shared papers)Francesco Boschetto (12 shared papers)Masaharu Shin‐Ya (12 shared papers)Toshiro Yamamoto (16 shared papers)
- Journals
- International Journal of Molecular Sciences (5 papers)Scientific Reports (3 papers)ACS Chemical Neuroscience (2 papers)Molecules (2 papers)ACS Infectious Diseases (2 papers)
- Partner nations
- JapanItalyUnited States
In The Last Decade
Eriko Ohgitani
35 papers receiving 655 citations
Peers
Comparison fields: 5 of 114
- Biophysics 92
- Infectious Diseases 196
- Biological Psychiatry 21
- Orthodontics 33
- Clinical Biochemistry 35
Countries citing papers authored by Eriko Ohgitani
This map shows the geographic impact of Eriko Ohgitani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eriko Ohgitani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eriko Ohgitani more than expected).
Fields of papers citing papers by Eriko Ohgitani
This network shows the impact of papers produced by Eriko Ohgitani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eriko Ohgitani. The network helps show where Eriko Ohgitani may publish in the future.
Co-authors
The 25 scholars most cited alongside Eriko Ohgitani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 76 | |
| 2 | 2021 | 60 | |
| 3 | 2021 | 43 | |
| 4 | 2020 | 43 | |
| 5 | 2019 | 37 | |
| 6 | 1994 | 30 | |
| 7 | 2022 | 26 | |
| 8 | 2020 | 26 | |
| 9 | 2021 | 24 | |
| 10 | 2021 | 23 | |
| 11 | 2022 | 23 | |
| 12 | 2021 | 22 | |
| 13 | 1999 | 22 | |
| 14 | 2019 | 20 | |
| 15 | 2021 | 20 | |
| 16 | 2022 | 20 | |
| 17 | 2021 | 19 | |
| 18 | 2018 | 17 | |
| 19 | 2020 | 15 | |
| 20 | 2022 | 14 |
About Eriko Ohgitani
Eriko Ohgitani is a scholar working on Infectious Diseases, Molecular Biology, Biomedical Engineering, Biophysics and Epidemiology, having authored 37 papers that have together received 664 indexed citations. Recurring topics across this work include Spectroscopy Techniques in Biomedical and Chemical Research (8 papers), Bone Tissue Engineering Materials (5 papers), SARS-CoV-2 and COVID-19 Research (5 papers), SARS-CoV-2 detection and testing (4 papers), Antifungal resistance and susceptibility (4 papers), Dental materials and restorations (4 papers), Antimicrobial agents and applications (3 papers) and Tea Polyphenols and Effects (3 papers). The work is most often cited by research in Biophysics (92 citations), Infectious Diseases (196 citations), Biological Psychiatry (21 citations), Orthodontics (33 citations) and Clinical Biochemistry (35 citations). Eriko Ohgitani has collaborated with scholars based in Japan, Italy and United States. Frequent co-authors include Osam Mazda, Wenliang Zhu, Elia Marin, Giuseppe Pezzotti, Tetsuya Adachi, Francesco Boschetto, Masaharu Shin‐Ya, Toshiro Yamamoto, Narisato Kanamura and Jirô Imanishi. Their work appears in journals such as International Journal of Molecular Sciences, Scientific Reports, ACS Chemical Neuroscience, Molecules and ACS Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.